Skip to main content
Premium Trial:

Request an Annual Quote

In Print: Last Week's Microarray Papers of Note: Apr 9, 2013


Density matters: comparison of array platforms for detection of copy-number variation and copy-neutral abnormalities.
Genet Med. 2013 Apr 4. [Epub ahead of print]
Mason-Suares H, Kim W, Grimmett L, et al.

The authors compared the ability of three commercial array platforms of varying density and content sold by Affymetrix, Agilent Technologies, and Oxford Gene Technology to detect copy-number variation and absence of heterozygosity. In the paper, the authors reported that while all three chips reliably detected copy-number variation, mosaicism, and uniparental isodisomy, AOH detection "varied significantly." Additional experiments and analyses led the authors to conclude that Affy's CytoScan, the array containing the greatest SNP content of the trio, "is best for detecting AOH."

BioArray News spoke recently about the study with corresponding author Katie Rudd, a cytogenetics director at Emory Genetics Laboratory (see related story, this issue).

Genome-wide association study of pre-eclampsia detects novel maternal single nucleotide polymorphisms and copy-number variants in subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study cohort.
Ann Hum Genet. 2013 Apr 2. [Epub ahead of print]
Zhao L, Bracken M, Dewan A.

The authors carried out a genome-wide association study to identify maternal variants associated with pre-eclampsia using samples from mothers with Afro-Caribbean, Hispanic, and European ancestry. European ancestry subjects were genotyped on Illumina Human610-Quad and Afro-Caribbean and Hispanic subjects were genotyped on Illumina Human1M-Duo BeadChip microarrays. They identified SNPs and copy-number variable regions that they claim present "interesting candidate genetic variants for pre-eclampsia that warrant further replication and investigation."

Genome-wide linkage analysis is a powerful prenatal diagnostic tool in families with unknown genetic defects.
Eur J Hum Genet. 2013 Apr;21(4):367-72.
Arélin M, Schulze B, Müller-Myhsok B, et al.

The authors present a family with a severe recessive mental retardation syndrome, where the mother wished pregnancy termination to avoid delivering another affected child. Using an Affymetrix genotyping array, they were able to establish the disease haplotype. Without knowing the exact genetic defect, they excluded the condition in the fetus. The woman finally gave birth to a healthy baby. The authors suggest that genome-wide linkage analysis based on either SNP mapping or full-genome sequencing could be a useful tool in prenatal diagnosis of diseases.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more